Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.

导出 OA

翻译打印收藏纠错

第一作者： Sang-Woo,Park

第一单位： Chonnam National University Hospital, Gwangju 61469, Korea.

作者： Sang-Woo,Park ^[1] ; Jiwoong,Lee ^[2] ; Michael S,Kook ^[3]

作者单位： Chonnam National University Hospital, Gwangju 61469, Korea. ^[1] Pusan National University Hospital, Busan 49241, Korea. ^[2] Department of Ophthalmology, Asan Medical Center, Seoul 05505, Korea. ^[3]

关键词 P-latanoprost dorzolamide/timolol glaucoma ocular surface disease preservative-free tafluprost

DOI 10.3390/ph15020201

PMID 35215313

发布时间 2022-03-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceuticals (Basel, Switzerland)

2022年15卷2期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史清除